Katelyn Byrne, Ph.D.
Credit: OHSU News
Katelyn Byrne, Ph.D., is senior author of a new OHSU study in the journal Immunity that identifies a potential path to making immunotherapy effective against pancreatic cancer. (OHSU/Christine Torres Hicks)
Credit: OHSU News
Katelyn Byrne, Ph.D., is senior author of a new OHSU study in the journal Immunity that identifies a potential path to making immunotherapy effective against pancreatic cancer. (OHSU/Christine Torres Hicks)